160 related articles for article (PubMed ID: 29799857)
1. The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.
Hernandez MJ; Dos Reis LM; Marques ID; Araujo MJ; Truyts CAM; Oliveira IB; Barreto FC; David-Neto E; Custodio MR; Moyses RM; Bellorin-Font E; Jorgetti V
PLoS One; 2018; 13(5):e0197994. PubMed ID: 29799857
[TBL] [Abstract][Full Text] [Related]
2. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
[TBL] [Abstract][Full Text] [Related]
3. Effect of zoledronic acid on vertebral marrow adiposity in postmenopausal osteoporosis assessed by MR spectroscopy.
Yang Y; Luo X; Yan F; Jiang Z; Li Y; Fang C; Shen J
Skeletal Radiol; 2015 Oct; 44(10):1499-505. PubMed ID: 26130070
[TBL] [Abstract][Full Text] [Related]
4. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
Cui P; Liu H; Sun J; Amizuka N; Sun Q; Li M
Histol Histopathol; 2018 Jan; 33(1):89-99. PubMed ID: 28345127
[TBL] [Abstract][Full Text] [Related]
5. Effect of zoledronate on the responses of osteocytes to acute parathyroid hormone.
Kuroshima S; Elliott KW; Yamashita J
Calcif Tissue Int; 2013 Jun; 92(6):576-85. PubMed ID: 23503790
[TBL] [Abstract][Full Text] [Related]
6. Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy.
Li GW; Chang SX; Fan JZ; Tian YN; Xu Z; He YM
Bone; 2013 Feb; 52(2):668-75. PubMed ID: 23142803
[TBL] [Abstract][Full Text] [Related]
7. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
[TBL] [Abstract][Full Text] [Related]
8. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
9. Changes in cortical bone channels network and osteocyte organization after the use of zoledronic acid.
Rabelo GD; Travençolo BA; Oliveira MA; Beletti ME; Gallottini M; Silveira FR
Arch Endocrinol Metab; 2015 Dec; 59(6):507-14. PubMed ID: 26331228
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid decreases bone formation without causing osteocyte death in mice.
Huja SS; Fernandez SA; Phillips C; Li Y
Arch Oral Biol; 2009 Sep; 54(9):851-6. PubMed ID: 19591974
[TBL] [Abstract][Full Text] [Related]
11. PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss.
Baroi S; Czernik PJ; Chougule A; Griffin PR; Lecka-Czernik B
Bone; 2021 Jun; 147():115913. PubMed ID: 33722775
[TBL] [Abstract][Full Text] [Related]
12. Tonsil-Derived Mesenchymal Stem Cells Promote Bone Mineralization and Reduce Marrow and Visceral Adiposity in a Mouse Model of Senile Osteoporosis.
Kim YH; Park M; Cho KA; Kim BK; Ryu JH; Woo SY; Ryu KH
Stem Cells Dev; 2016 Aug; 25(15):1161-71. PubMed ID: 27245267
[TBL] [Abstract][Full Text] [Related]
13. Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation.
Hari P; DeFor TE; Vesole DH; Bredeson CN; Burns LJ
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1361-7. PubMed ID: 23806773
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis.
Brennan O; Kennedy OD; Lee TC; Rackard SM; O'Brien FJ
J Orthop Res; 2011 Mar; 29(3):419-24. PubMed ID: 20886644
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA
J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515
[TBL] [Abstract][Full Text] [Related]
16. Inverse correlation between trabecular bone volume and bone marrow adipose tissue in rats treated with osteoanabolic agents.
Costa S; Fairfield H; Reagan MR
Bone; 2019 Jun; 123():211-223. PubMed ID: 30954729
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Recker RR; Delmas PD; Halse J; Reid IR; Boonen S; García-Hernandez PA; Supronik J; Lewiecki EM; Ochoa L; Miller P; Hu H; Mesenbrink P; Hartl F; Gasser J; Eriksen EF
J Bone Miner Res; 2008 Jan; 23(1):6-16. PubMed ID: 17892374
[TBL] [Abstract][Full Text] [Related]
18. An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trial.
Grigg A; Butcher B; Khodr B; Bajel A; Hertzberg M; Patil S; D'Souza AB; Ganly P; Ebeling P; Wong E
Bone Marrow Transplant; 2017 Sep; 52(9):1288-1293. PubMed ID: 28628088
[TBL] [Abstract][Full Text] [Related]
19. Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein.
Gerard DA; Carlson ER; Gotcher JE; Pickett DO
J Oral Maxillofac Surg; 2014 Jan; 72(1):61-6. PubMed ID: 23891015
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms.
Chandra A; Lin T; Young T; Tong W; Ma X; Tseng WJ; Kramer I; Kneissel M; Levine MA; Zhang Y; Cengel K; Liu XS; Qin L
J Bone Miner Res; 2017 Feb; 32(2):360-372. PubMed ID: 27635523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
